In these studies, they re-introduced CXCL12 expression in colorectal cancer cells which prevented their ability to adhere to underlying proteins. Plus, the floating cells underwent programmed cell death.

The research will be presented at the American Association for Cancer Research meeting in Denver, April 21. (ANI)